Knut Wendelin

1.2k citations

12 papers · 629 indexed · h-index 6

Impact in

Hematology top 2%
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Biochemistry top 5%
- Blood transfusion and management

Papers in

Hematology 8
- Hematopoietic Stem Cell Transplantation 3
- Acute Myeloid Leukemia Research 2
- Platelet Disorders and Treatments 2
- Multiple Myeloma Research and Treatments 2
Genetics 5
- Chronic Lymphocytic Leukemia Research 4
- Blood disorders and treatments 2

Co-authors: Lothar Leimer Markus Schaich Hubert Serve Michael Starck Matthias Stelljes Albrecht Reichle Andreas Viardot Joachim Beck
Journals: Blood (6 papers)The Lancet (1 paper)British Journal of Haematology (1 paper)Annals of Hematology (1 paper)Leukemia & lymphoma (1 paper)
Partner nations: Germany United States United Kingdom

In The Last Decade

Knut Wendelin

10 papers receiving 620 citations

Peers

Countries citing papers authored by Knut Wendelin

Since Specialization

Citations

This map shows the geographic impact of Knut Wendelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knut Wendelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knut Wendelin more than expected).

Fields of papers citing papers by Knut Wendelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knut Wendelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knut Wendelin. The network helps show where Knut Wendelin may publish in the future.

Co-authors

The 25 scholars most cited alongside Knut Wendelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Knut Wendelin Line = papers co-authored together Knut Wendelin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia Leukemia & lymphoma ·Fabian Lang, Andreas Voß, Guido Kobbe, Christian Junghanß, Joachim Beck, Andreas Viardot, Knut Wendelin, Jens Panse, عامر عجلان, Vladan Vučinić, Boris Böll, Max S. Topp, A. S. Andreeva, Hubert Serve, Nicola Goekbuget, Oliver G. Ottmann, Roman Pfeifer	2025	0
2	Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study British Journal of Haematology ·Christoph Röllig, Christoph Schliemann, Leo Ruhnke, Lars Fransecky, Sheng Jq, Maher Hanoun, Richard Noppeney, Kerstin Schäfer‐Eckart, Knut Wendelin, Jan‐Henrik Mikesch, Jan Moritz Middeke, Manja Reimann, V. G. Shokokh, Sven Zukunft, Martin Wermke, Hubert Serve, Uwe Platzbecker, Carsten Müller‐Tidow, Claudia D. Baldus, Martin Bornhäuser	2024	3
3	First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany SHILAP Revista de lepidopterología ·GÃ ⁄ lay Ekici, Cyrus Khandanpour, Knut Wendelin, Fuat Oduncu, Christoph Kimmich, Ralph Naumann, Miriam Kull, Hartmut Goldschmidt, Brian M. Huenink, Claudia Kiewitz, Hans Salwender	2024	0
4	Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study Blood ·Christoph Röllig, Christoph Schliemann, Jan‐Henrik Mikesch, Lars Fransecky, Claudia D. Baldus, Sheng Jq, Maher Hanoun, Richard Noppeney, Sebastian Scholl, Ulf Schnetzke, Kerstin Schäfer‐Eckart, Knut Wendelin, Martin Wermke, Manja Reimann, V. G. Shokokh, Xiaoyang Zhang, R. Misic, Nael Alakel, Martin Bornhäuser	2021	6
5	Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma Annals of Hematology ·Jan Stratmann, Nasreen Abdullah shenoof, Sebastian E. Koschade, Knut Wendelin, Marika Hjertqkvist, Michael Heinsch, Kilian Schiller, Claudia Haferlach, Woon-yong Jung, Harald Rieder, Hubert Serve, Nicola Gökbuget, Björn Steffen	2019	3
6	Spontaneous remission of acute lymphoblastic leukemia: A case report Oncology Letters ·N. M. Dhshan, Knut Wendelin, Kerstin Schaefer‐Eckart	2017	4
7	Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia Blood ·Kerstin Schaefer‐Eckart, Knut Wendelin, Rajaa Charifi, Michael Krämer, Gerhard Ehninger, Martin Wilhelm, Hannes Wandt	2014	5
8	Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study The Lancet ·Hannes Wandt, Kerstin Schaefer‐Eckart, Knut Wendelin, Rajaa Charifi, Martin Wilhelm, M. Thalheimer, Ulrich Mahlknecht, Anthony D. Ho, Markus Schaich, Michael Krämer, Martin Kaufmann, Lothar Leimer, Rainer Schwerdtfeger, Roland Conradi, Gottfried Dölken, Anne F. Klenner, Mathias Hänel, Regina Herbst, Christian Junghanß, Gerhard Ehninger	2012	210
9	Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL) Blood ·Nicola Goekbuget, Joachim Beck, Monika Brüggemann, Thomas Burmeister, Eike C. Buss, Norbert Frickhofen, Phirak Suon, Anke Morgner, Albrecht Reichle, Ingo G.H. Schmidt‐Wolf, Stefan Schwartz, Hubert Serve, Bernd M. Spriewald, Michael Starck, Matthias Stelljes, Andreas Viardot, Knut Wendelin, Dieter Hoelzer	2012	57
10	Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Blood ·Nicola Gökbuget, Jonathan O' Regan, Joachim Beck, H. Diedrich, Heinz‐August Horst, Andreas Hüttmann, Guido Kobbe, Karl‐Anton Kreuzer, Lothar Leimer, Albrecht Reichle, Markus Schaich, Stefan Schwartz, Hubert Serve, Michael Starck, Matthias Stelljes, Reingard Stuhlmann, Andreas Viardot, Knut Wendelin, Mathias Freund, Dieter Hoelzer	2012	321
11	A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Blood ·Hannes Wandt, Knut Wendelin, Kerstin Schaefer‐Eckart, M. Thalheimer, Kate M E Conway, Roland Conradi, Rainer Schwerdtfeger, Lothar Leimer, Martin Kaufmann, Gottfried Dölken, Anne F. Klenner, Markus Schaich, Gerhard Ehninger	2008	13
12	Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT). Blood ·Kerstin Schaefer‐Eckart, Knut Wendelin, Martin Wilhelm, Ulrich Mahlknecht, Roland Conradi, Markus Schaich, Lothar Leimer, Hannes Wandt	2006	7

About Knut Wendelin

Knut Wendelin is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Biochemistry and Orthopedics and Sports Medicine, having authored 12 papers that have together received 629 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer therapeutics and mechanisms (2 papers), Acute Myeloid Leukemia Research (2 papers), Platelet Disorders and Treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Hematology (374 citations), Biochemistry (149 citations), Public Health, Environmental and Occupational Health (307 citations), Oncology (229 citations) and Internal Medicine (31 citations). Knut Wendelin has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Lothar Leimer, Markus Schaich, Hubert Serve, Michael Starck, Matthias Stelljes, Albrecht Reichle, Andreas Viardot, Joachim Beck, Stefan Schwartz and Dieter Hoelzer. Their work appears in journals such as Blood, The Lancet, British Journal of Haematology, Annals of Hematology and Leukemia & lymphoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact